Brain stimulation and other biological non-pharmacological interventions in mental disorders: an umbrella review

S Rosson, R De Filippis, G Croatto, E Collantoni… - Neuroscience & …, 2022 - Elsevier
Background The degree of efficacy, safety, quality, and certainty of meta-analytic evidence of
biological non-pharmacological treatments in mental disorders is unclear. Methods We …

[HTML][HTML] Efficacy and safety of clozapine in psychotic disorders—a systematic quantitative meta-review

E Wagner, S Siafis, P Fernando, P Falkai… - Translational …, 2021 - nature.com
A recent increase in the literature regarding the evidence base for clozapine has made it
increasingly difficult for clinicians to judge “best evidence” for clozapine use. As such, we …

Treatment resistant schizophrenia: Clinical, biological, and therapeutic perspectives

FC Nucifora Jr, E Woznica, BJ Lee, N Cascella… - Neurobiology of …, 2019 - Elsevier
Abstract Treatment resistant schizophrenia (TRS) refers to the significant proportion of
schizophrenia patients who continue to have symptoms and poor outcomes despite …

Efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia: a network meta-analysis

MT Samara, M Dold, M Gianatsi… - JAMA …, 2016 - jamanetwork.com
Importance In treatment-resistant schizophrenia, clozapine is considered the standard
treatment. However, clozapine use has restrictions owing to its many adverse effects …

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of …

A Hasan, P Falkai, T Wobrock… - The World Journal of …, 2012 - Taylor & Francis
These updated guidelines are based on a first edition of the World Federation of Societies of
Biological Psychiatry Guidelines for Biological Treatment of Schizophrenia published in …

[PDF][PDF] Treatment of patients with schizophrenia

AF Lehman, LB Dixon, TH McGlashan… - American Psychiatric …, 2010 - umh1946.umh.es
Originally published in February 2004. This guideline is more than 5 years old and has not
yet been updated to ensure that it reflects current knowledge and practice. In accordance …

Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents

S Miyamoto, N Miyake, LF Jarskog… - Molecular …, 2012 - nature.com
Since the introduction of chlorpromazine and throughout the development of the new-
generation antipsychotic drugs (APDs) beginning with clozapine, the D 2 receptor has been …

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

JA Lieberman, TS Stroup, JP McEvoy… - New England journal …, 2005 - Mass Medical Soc
Background The relative effectiveness of second-generation (atypical) antipsychotic drugs
as compared with that of older agents has been incompletely addressed, though newer …

Clashing diagnostic approaches: DSM-ICD versus RDoC

SO Lilienfeld, MT Treadway - Annual review of clinical …, 2016 - annualreviews.org
Since at least the middle of the past century, one overarching model of psychiatric
classification has reigned supreme, namely, that of the Diagnostic and Statistical Manual of …

Descending control of pain

MJ Millan - Progress in neurobiology, 2002 - Elsevier
Upon receipt in the dorsal horn (DH) of the spinal cord, nociceptive (pain-signalling)
information from the viscera, skin and other organs is subject to extensive processing by a …